Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2012; 18(18): 2253-2261
Published online May 14, 2012. doi: 10.3748/wjg.v18.i18.2253
Published online May 14, 2012. doi: 10.3748/wjg.v18.i18.2253
Table 2 Correlation analysis of CD74, migration inhibitory factor and toll-like receptor 4 epithelial staining in 120 human gastric cancer patients
| MIF expression | r | P | TLR4 expression | r | P | TLR4 expression | r | P | |||||||||
| CD74 | (+) | (-) | Total | 0.2367 | < 0.01 | CD74 | (+) | (-) | Total | 0.4414 | < 0.01 | MIF | (+) | (-) | Total | 0.5501 | < 0.01 |
| (+) | 85 | 15 | 100 | (+) | 90 | 10 | 100 | (+) | 89 | 8 | 97 | ||||||
| (-) | 12 | 8 | 20 | (-) | 9 | 11 | 20 | (-) | 10 | 13 | 23 | ||||||
| Total | 97 | 23 | 120 | Total | 99 | 21 | 120 | Total | 99 | 21 | 120 | ||||||
- Citation: Zheng YX, Yang M, Rong TT, Yuan XL, Ma YH, Wang ZH, Shen LS, Cui L. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer. World J Gastroenterol 2012; 18(18): 2253-2261
- URL: https://www.wjgnet.com/1007-9327/full/v18/i18/2253.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i18.2253